CTC‐490G23.2 acts as a molecular scaffold, enhancing the binding ability of CD44 mRNA with PTBP1, regulating CD44 splicing, and promoting ESCA cancer invasion and metastasis77 (Figure 3E). Here, CD44 is linked to cancer.